logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Cytotherapy cover

Cytotherapy

IF3.2
Papers4622
Citations6694
Journal Papers 8265
Publication Date
delete
Safety, efficacy, and PK/PD of a BCMA-targeted CAR-NK cell therapy (LUCAR-B68) in relapsed/refractory multiple myeloma: a phase I study
deleteCytotherapy
IF3.2
delete2026-10-02
delete0
PREAI
deleteShan Meng; Fangxia Wang; Ying Shen; Yang Zhang; Xuehong Ma; Aili He; Wanhong Zhao
deleteShare
deleteSave
Sustainable Point-of-Care Manufacturing of Cell and Gene Therapies: Operational, Regulatory and Economic Pathways for Implementation
deleteCytotherapy
IF3.2
delete2026-09-29
delete0
PREAI
deleteFolashade Otegbeye; Patrick J. Hanley; Emily L. Hopewell; Bambi J. Grilley; Olive Sturtevant; Joanne Kurtzberg; Rob Tressler
deleteShare
deleteSave
What Drives Investment in Cell and Gene Therapy? Evidence from a Global Investor Survey of 100 Investors
deleteCytotherapy
IF3.2
delete2026-09-23
delete0
PREAI
deleteKsenia Bezverbnaya; Sandeep Mangrati; Asthika Goonewardene; Vered Gigi; Sven Kili; Patrick Rivers
deleteShare
deleteSave
Interferon γ MSC accumulation in the lungs is mediated by integrin α4β1 adhesion
deleteCytotherapy
IF3.2
delete2026-09-20
delete0
PREAI
deleteElisabetta M. Foppiani; Andre J. Burnham; Edwin M. Horwitz
deleteShare
deleteSave
Out of Specification frameworks may overestimate clinical risk: a lesson from commercial CAR-T products deviations
deleteCytotherapy
IF3.2
delete2026-09-19
delete0
PREAI
deleteNatalia O. Ivanova; Anna I. Serdyuk; Ekaterina I. Fefelova; Arseniy E. Yuzhalin; Apollinariya V. Bogolyubova
deleteShare
deleteSave
Pediatric autologous T-cell apheresis: does collection difficulty also predict manufacturing outcomes?
deleteCytotherapy
IF3.2
delete2026-09-17
delete0
PREAI
deleteWamiq Saeed; Zain ul Abideen Rao
deleteShare
deleteSave
Characterization of Lentiviral Vector Products Using Orthogonal Measurements
deleteCytotherapy
IF3.2
delete2026-09-17
delete0
PREAI
deleteJerilyn R. Izac; Zhiyong He; Linhua Tian; Edward Kwee; Sahana Audithan; Lili Wang
deleteShare
deleteSave
Patient access to cell and gene therapies through the European hospital exemption pathway in the Netherlands
deleteCytotherapy
IF3.2
delete2026-09-16
delete0
deleteOAAI
deleteChristine C. van Hattem; Lourens T. Bloem; Christianne M.A. Reijnders; Gwylim E.P.J. Janssens; Toine C.G. Egberts; Babs O. Fabriek
deleteShare
deleteSave
Large-particle T-cell activation improves manufacturability, reduces phagocytic loss, and enhances CAR-T cell cytotoxic function
deleteCytotherapy
IF3.2
delete2026-09-09
delete0
deleteOAAI
deleteMatic Bartol; Tina Fink; Tina Tragin; Ema Pleško; Roman Jerala; Hana Esih; Aljaž Kravanja; Brina Štante; Valentina Bianco; Luka Fajs; Mojca Jež
deleteShare
deleteSave
Calibrated prediction of CD34+ yield and apheresis product CD34+ concentration for allogeneic donor collection planning
deleteCytotherapy
IF3.2
delete2026-09-07
delete0
PREAI
deleteHilmi Erdem Gözden; Bedrettin Orhan; Nihan Alkış
deleteShare
deleteSave
Toward Harmonization: Standardizing Apheresis-Derived Starting Materials for Cell Therapy Manufacturing
deleteCytotherapy
IF3.2
delete2026-09-05
delete0
PREAI
deleteRobin K. White; Christina M. Celluzzi; Yen-Michael S. Hsu; Joseph (Yossi) Schwartz
deleteShare
deleteSave
Semi-automated manufacturing preserves memory-associated and metabolic features of piggyBac CAR-T cells
deleteCytotherapy
IF3.2
delete2026-09-04
delete0
PREAI
deleteKonomi Morita; Megumi Wada; Moe Washizawa; Tomoya Inoue; Hidemi Sato; Akane Miura; Yuko Yaguchi; Fumi Saito; Takafumi Mano; Momona Hirayama; Tsuyoshi Shiranita; Toshikazu Yamaoka; Aiko Hasegawa; Kazumasa Yokoyama; Yoichi Inada; Takuji Achiwa; Miyuki Tanaka; Yozo Nakazawa; Shigeki Yagyu
deleteShare
deleteSave
Allogeneic CAR-T cell engineering: immune stealth, product fitness, and clinical translation
deleteCytotherapy
IF3.2
delete2026-09-03
delete0
PREAI
deleteRuyue Yang; Xue Mi; Zhanping Li; Kai Yan; Zhongdang Xiao
deleteShare
deleteSave
Overcoming access barriers in European CAR-T therapy: the role of decentralized manufacturing and the EASYGEN framework
deleteCytotherapy
IF3.2
delete2026-09-01
delete0
PREAI
deleteGriebling, Dominik; Scheiwe, Anna Rebecca; Kuhlen, Ralf; Zech, Chloe; Mueller, Pia; Rische, Christian; Laengst, Vivian; Wegener, Chris; Schmidt, Lexie; Bothwell, Paige; Thompson, Kyle; Mestermann, Katrin; Sanges, Carmen; Krones, David; Mueller, Mirko; Duenkel, Anna; Hudecek, Michael; Koehl, Ulrike; Hendel, Ayal; Kashanin, Dmitry; Williams, Vivienne; Schueler, Julia; Bolanos, Natacha; McNamara, Louise; Rintala, Tuula; Sureda, Anna; Gandjour, Afschin; Ahrens, Theresa D.; Mennig, Patrick; Groen, Eduard Christiaan; Glass, Bertram; Vosen, Agnes; Busch-Casler, Julia; Radic, Marija; Teichert, Anika; Hoffmann, Ralf; Brzoska, Thomas; Pietralla, Catrina; Brunner, Jens O.; Kagerbauer, Theresa; Zuendorf, Christin; Baillie, George S.; Phanthaphol, Nattaporn; Prosper, Felipe; Madoz, Juan R. Rodriguez; Carames, Cristina; Steppan, Sonja
deleteShare
deleteSave
Regulating the Unviable: A Call to FDA for a Rare Biologic Limited Approval (RBLA) Pathway
deleteCytotherapy
IF3.2
delete2026-08-28
delete0
PREAI
deleteKevin Bosse; Patrick J. Hanley; Joanna Kurtzberg; Olive Sturtevant; Emily Hopewell; Rebecca Gardner; Bambi J. Grilley
deleteShare
deleteSave
Estimating the costs of advanced therapy medicinal products: a systematic review
deleteCytotherapy
IF3.2
delete2026-08-24
delete0
deleteOAAI
deleteMelanio Mauricio; Dominic Fernandez; Mara Tihaya; Pauline Meij; Megan Munsie; Wilbert van den Hout
deleteShare
deleteSave
Flow Cytometry in Cell and Gene Therapy:Principles, Practices, and Perspectives
deleteCytotherapy
IF3.2
delete2026-08-19
delete0
PREAI
deleteChristian R. Aguilera-Sandoval
deleteShare
deleteSave
Model-Predicted Fludarabine Exposure and Outcomes after Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
deleteCytotherapy
IF3.2
delete2026-08-19
delete0
deleteOAAI
deleteSusie Long; Veronika Bachanova; Qing Cao; Christen L. Ebens; Troy C. Lund; Margaret L MacMillan; Alex Hoover
deleteShare
deleteSave
Hypoxia during GPC2-CAR T-cell manufacturing compromises cell expansion and cytotoxic capacity
deleteCytotherapy
IF3.2
delete2026-08-08
delete0
deleteOAAI
deleteIra Phadke; Ryan Hannon; Mary Black; Zoe Schmiechen; Hannah W. Song; Haiyan Lei; Jack Shern; Michaela Prochazkova; Jangsuk Oh; Mitchell Ho; Steven L. Highfill; Rosa Nguyen
deleteShare
deleteSave
Gene therapy for sickle cell disease: early lessons, enduring questions
deleteCytotherapy
IF3.2
delete2026-08-08
delete0
PREAI
deleteAlice Bertaina; David Shyr
deleteShare
deleteSave